Chinese EV giant BYD launches new plug-in hybrid sedan with lower starting price By Reuters
[ad_1] © Reuters. A view of the logo of BYD on the BYD Seal at a press day of the Japan Mobility Show 2023 at...
Goldman Sachs raises S&P 500 price target on earnings strength By Investing.com
[ad_1] © Reuters. Just In: Goldman Sachs raises S&P 500 price target (Updated – February 17, 2024 5:31 AM EST) Goldman Sachs equity strategists raised...
Abbott announces 401st consecutive dividend, price set at 55 cents per share By Investing.com
[ad_1] © Reuters. ABBOTT PARK, Ill. – Abbott (NYSE:ABT) has declared a quarterly common dividend of 55 cents per share, continuing its long-standing tradition of...
Crypto stocks rally as Bitcoin price continues to climb By Investing.com
[ad_1] © Reuters. Crypto stocks rally as Bitcoin price continues to climb Cryptocurrency stocks are rising Wednesday on the back of the continued climb in...
BMO raises HubSpot price target to $710 on growth outlook By Investing.com
[ad_1] © Reuters. On Monday, BMO Capital Markets updated its outlook on HubSpot Inc (NYSE:) by increasing the price target to $710 from the previous...
Citi sets Rocket Lab Buy rating with $6 price target By Investing.com
[ad_1] © Reuters. On Monday, Citi reinstated coverage on Rocket Lab USA (NASDAQ:RKLB), issuing a Buy rating and establishing a price target of $6.00. The...
Palm oil buyers switch to cheaper rival oils, hampering price recovery By Reuters
[ad_1] © Reuters. Trucks are seen near a palm oil plantation at a village located near Indonesia’s projected new capital, known as Nusantara National Capital,...
CFRA cuts Neste Oyj stock rating to hold, slashes price target By Investing.com
[ad_1] © Reuters. On Friday, CFRA downgraded shares of Neste Oyj (NESTE:FH) (OTC: NTOIY) from a Strong Buy to a Hold, significantly reducing the price...
Motorola reports robust FQ4 earnings, analysts raise price target By Investing.com
[ad_1] © Reuters. Motorola (MSI) reports robust FQ4 earnings, analyst raises price target Motorola Solutions (NYSE:) reported better-than-anticipated earnings for the fiscal fourth quarter, but...
West Pharmaceutical upgraded to buy, price target jumps to $536 By Investing.com
[ad_1] © Reuters. On Wednesday, West Pharmaceutical Services Inc . (NYSE:) received an upgrade from a Jefferies analyst, elevating the stock’s status from Hold to...